Neurogenic Detrusor Overactivity
📧 Sign up to get email alerts when something new happens for Neurogenic Detrusor Overactivity.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-07-31Clinical Trial Update: Extended-Release Oxybutynin for the Treatment of Neurogenic Detrusor Overactivity [Phase 4]
This Phase 4 trial of extended-release oxybutynin for neurogenic detrusor overactivity was terminated. Results were posted in July 2013.
-
CLINICAL_TRIALS trial_result · 2013-04-08Clinical Trial Update: Comparative Study of the Efficacy and Safety of Muscarinic M3 Receptors Antagonists in the Treatment of Neurogenic Detrusor Overactivity [Phase 4]
Phase 4 clinical trial update evaluating the efficacy and safety of muscarinic M3 receptor antagonists for neurogenic detrusor overactivity …
-
CLINICAL_TRIALS trial_result · 2012-02-10Clinical Trial Update: Efficacy and Tolerability of Propiverine Hydrochloride in Patients With Neurogenic Detrusor Overactivity [Phase 3]
Phase 3 trial evaluating propiverine hydrochloride for neurogenic detrusor overactivity has completed.
-
CLINICAL_TRIALS trial_result · 2011-11-22Clinical Trial Update: A Comparison Study of Oxybutynin and Botulinum Toxin for Neurogenic Detrusor Overactivity [NA]
This completed trial compared oxybutynin and botulinum toxin for neurogenic detrusor overactivity in individuals with spinal cord injury.
-
CLINICAL_TRIALS trial_result · 2011-11-17Clinical Trial Update: Study Of Fesoterodine In Pediatric Overactive Bladder Patients Aged 8-17 Years [Phase 2]
Phase 2 clinical trial of fesoterodine in pediatric patients (ages 8-17) with overactive bladder or neurogenic detrusor overactivity has bee…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-04-30Clinical Trial Update: A Study Evaluating Oxybutynin in Patients With Neurogenic Overactive Bladder Associated With a Neurological Condition [Phase 4]
Phase 4 study evaluating oxybutynin for neurogenic detrusor overactivity has completed, with results posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-03-24Clinical Trial Update: Intravesical Injection of Botulinum Toxin A Versus Saline for Neurogenic Detrusor Overactivity [Phase 3]
A Phase 3 trial comparing intravesical injections of botulinum toxin A to saline for neurogenic detrusor overactivity has completed.